Population Pharmacokinetics of Fentanyl in Patients Undergoing Living Donor Liver Transplantation
Status:
Completed
Trial end date:
2010-10-01
Target enrollment:
Participant gender:
Summary
The aim of this study was to characterize pharmacokinetics of fentanyl during and after
Living Donor Liver Transplantation (LDLT), using population pharmacokinetic analysis with non
linear mixed effects modeling.